ISIN | LU0687943661 |
---|---|
Valor Number | 12495254 |
Bloomberg Global ID | |
Fund Name | GAMCO Merger Arbitrage Class A EUR |
Fund Provider |
GAMCO International SICAV
SICAV Team E-Mail: SicavInfo@gabelli.com Phone: +1 914 921-5135 Web: gabelli.com/funds/sicavs |
Fund Provider | GAMCO International SICAV |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Sub-Fund’s primary objective is to invest in announced equity merger and acquisition transactions and maintain a diversified portfolio of transactions. The Sub-Fund seeks to achieve long term capital growth by engaging in risk arbitrage strategies. |
Peculiarities |
Current Price * | 12.75 EUR | 03.07.2024 |
---|---|---|
Previous Price * | 12.70 EUR | 02.07.2024 |
52 Week High * | 13.04 EUR | 28.03.2024 |
52 Week Low * | 12.44 EUR | 06.07.2023 |
NAV * | 12.75 EUR | 03.07.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 438,177,166 | |
Unit/Share Assets *** | 37,500,678 | |
Trading Information SIX |
YTD Performance | -1.87% |
29.12.2023 - 03.07.2024
29.12.2023 03.07.2024 |
---|---|---|
YTD Performance (in CHF) | +2.75% |
29.12.2023 - 03.07.2024
29.12.2023 03.07.2024 |
1 month | -0.15% |
03.06.2024 - 03.07.2024
03.06.2024 03.07.2024 |
3 months | -1.99% |
03.04.2024 - 03.07.2024
03.04.2024 03.07.2024 |
6 months | -1.60% |
03.01.2024 - 03.07.2024
03.01.2024 03.07.2024 |
1 year | +1.94% |
03.07.2023 - 03.07.2024
03.07.2023 03.07.2024 |
2 years | +2.71% |
05.07.2022 - 03.07.2024
05.07.2022 03.07.2024 |
3 years | +0.72% |
06.07.2021 - 03.07.2024
06.07.2021 03.07.2024 |
5 years | +13.23% |
03.07.2019 - 03.07.2024
03.07.2019 03.07.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Horizon Therapeutics PLC | 5.51% | |
---|---|---|
Activision Blizzard Inc | 4.14% | |
IVERIC bio Inc | 4.05% | |
PNM Resources Inc | 4.03% | |
National Instruments Corp | 3.75% | |
Univar Solutions Inc | 3.72% | |
Aerojet Rocketdyne Holdings Inc | 3.43% | |
Swap Cash Payable Usd | 3.30% | |
Tegna Inc | 2.97% | |
Albertsons Companies Inc Class A | 2.80% | |
Last data update | 30.06.2023 |
TER *** | 1.78% |
---|---|
TER date *** | 31.12.2023 |
Performance Fee *** | 15.00% |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.73% |
SRRI ***
|
|
SRRI date *** | 30.06.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |